Einrichtungen, die nicht zum Universitätsklinikum Erlangen gehören

Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022) Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, et al. Journal article Oxidized Hyaluronic Acid-Gelatin-Based Hydrogels for Tissue Engineering and Soft Tissue Mimicking (2022) Kuth S, Karakaya E, Reiter N, Schmidt LP, Paulsen F, Tessmar J, Budday S, Boccaccini AR Journal article Two adjacent phosphorylation sites in the C-terminus of the channel’s α-subunit have opposing effects on epithelial sodium channel (ENaC) activity (2022) Diakov A, Nesterov V, Dahlmann A, Korbmacher C Journal article Cyclic changes of sensory parameters in migraine patients (2022) Helfenstein C, Strupf M, Stefke A, Fraunberger B, Renner B, Suchantke I, Rothermel M, et al. Journal article De novo variants in the PABP domain of PABPC1 lead to developmental delay (2022) Wegler M, Jia X, Alders M, Bouman A, Chen J, Duan X, Lauzon JL, et al. Journal article Merging bioresponsive release of insulin-like growth factor I with 3D printable thermogelling hydrogels (2022) Beudert M, Hahn L, Horn A, Hauptstein N, Sticht H, Meinel L, Luxenhofer R, et al. Journal article, Original article De novo variants in ATP2B1 lead to neurodevelopmental delay (2022) Rahimi MJ, Urban N, Wegler M, Sticht H, Schaefer M, Popp B, Gaunitz F, et al. Journal article Peculiarities in the panoramic radiograph of patients with secondary hyperparathyroidism due to terminal renal disease: a radiologic controlled comparative study (2022) Möst T, Jahn AE, Heller KM, Schiffer M, Adler W, Rohde M, Weber M, et al. Journal article GENERATION OF PATIENT-SPECIFIC HIPSC-PODOCYTES TO STUDY PHENOTYPE-SPECIFIC ALTERATIONS AND TEST THERAPEUTIC TARGETS EX VIVO (2022) Rose V, Sopel N, Ohs A, Warnecke C, Schiffer M, Müller-Deile J Conference contribution Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring (2022) Fekete S, Guentzel T, Egberts K, Geissler J, Neubert AC, Gerlach M, Romanos M, Taurines R Conference contribution